324
Participants
Start Date
August 22, 2016
Primary Completion Date
December 15, 2016
Study Completion Date
December 15, 2016
ELLIPTA DPI
It is the inhaler with two blister strips containing white coloured powder, one placebo strip containing lactose monohydrate and a second placebo strip containing lactose monohydrate blended with magnesium stearate. It is given as oral inhalation (Inhalation powder)
GSK MDI
It is the placebo inhaler with clear liquid containing propellant (1,1,1, 2- Tetrafluoroethane). It is given as oral inhalation (Inhalation Aerosol).
AZ MDI
It is the placebo inhaler with clear liquid. It is given as oral inhalation (Inhalation Aerosol).
GSK Investigational Site, Baltimore
GSK Investigational Site, Raleigh
GSK Investigational Site, Charlotte
GSK Investigational Site, Spartanburg
GSK Investigational Site, Miami
GSK Investigational Site, Aventura
GSK Investigational Site, Clearwater
GSK Investigational Site, Canton
GSK Investigational Site, Cincinnati
GSK Investigational Site, Plymouth
GSK Investigational Site, Warrensburg
GSK Investigational Site, Columbia
GSK Investigational Site, Rolla
GSK Investigational Site, Oklahoma City
GSK Investigational Site, Waco
GSK Investigational Site, San Antonio
GSK Investigational Site, Huntington Beach
GSK Investigational Site, Medford
GSK Investigational Site, North Dartmouth
GSK Investigational Site, Orangeburg
Lead Sponsor
GlaxoSmithKline
INDUSTRY